Brief: Beyondspring Presents Positive Data On Plinabulin From Its Neutropenia Prevention Program
16/09/2021 12:22
Sept 16 (Reuters) - Beyondspring Inc BYSI.O :
* BEYONDSPRING PHARMACEUTICALS ANNOUNCES NEW POSITIVE DATA
ON
PLINABULIN FROM ITS CHEMOTHERAPY-INDUCED NEUTROPENIA PREVENTION
PROGRAM AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 2021
CONGRESS
Source text for Eikon: ID:nGNXmmMyw
Further company coverage: BYSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beyondspring
See all newsBrief: Beyondspring Inc Entered Into Open Market Sale Agreement Under Which Co May Offer And Sell Up To 9.2 Million Ordinary Shares
Brief: Beyondspring Announces FDA Fast Track Designation For Plinabulin In Post-Ici Non-Squamous Nsclc And Strategic Transaction To Advance Global Phase 3 Dublin-4 Trial Toward Planned Interim Analysis
NASDAQ RESUMED AT 12:26 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:21 PM
Brief: Beyondspring Announces Leadership Transition To Deliver Focused Execution On Its Confirmatory Dublin-4 Program And Long-Term Value